Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -1.24%14.93M | 41.37%16.28M | -14.87%15.09M | -6.44%58M | -14.30%13.68M | -3.98%15.12M | -25.77%11.51M | 19.90%17.73M | -19.64%62M | -21.06%15.96M |
| Cost of revenue | -5.08%7.78M | 26.09%7.56M | 2.00%7.75M | -11.80%28.31M | -23.43%6.57M | 0.42%8.19M | -16.62%6M | -6.95%7.6M | -9.74%32.09M | 0.08%8.58M |
| Gross profit | 3.29%7.16M | 58.01%8.71M | -27.51%7.34M | -0.69%29.7M | -3.71%7.11M | -8.70%6.93M | -33.68%5.51M | 53.00%10.13M | -28.10%29.9M | -36.61%7.39M |
| Operating expense | -25.44%6.3M | 8.23%8.07M | -4.95%8.55M | -1.39%31.56M | -8.76%7.57M | -0.86%8.45M | -7.30%7.46M | 12.69%9M | -21.61%32.01M | -17.21%8.29M |
| Selling and administrative expenses | ---- | ---- | ---- | -3.48%30.14M | ---- | ---- | ---- | ---- | -18.36%31.23M | ---- |
| -Selling and marketing expense | ---- | ---- | ---- | -3.28%20.74M | ---- | ---- | ---- | ---- | -22.40%21.44M | ---- |
| -General and administrative expense | ---- | ---- | ---- | -3.90%9.41M | ---- | ---- | ---- | ---- | -7.88%9.79M | ---- |
| Other operating expenses | -25.44%6.3M | 8.23%8.07M | -4.95%8.55M | 30.85%1.66M | -8.76%7.57M | -0.86%8.45M | -7.30%7.46M | 12.69%9M | -53.27%1.27M | 129.51%8.29M |
| Total other operating income | ---- | ---- | ---- | -50.57%242.84K | ---- | ---- | ---- | ---- | 241.29%491.3K | ---- |
| Operating profit | 156.52%858K | 132.85%639K | -206.53%-1.21M | 11.29%-1.87M | 49.89%-454K | -63.05%-1.52M | -825.75%-1.95M | 183.26%1.13M | -378.17%-2.11M | -155.40%-906K |
| Net non-operating interest income (expenses) | 7.07%-92K | 3.85%-100K | 27.69%-94K | 1.98%523K | 2.03%-145K | 0.00%-99K | -13.04%-104K | -15.04%-130K | 82.78%512.85K | -124.73%-148K |
| Non-operating interest income | ---- | ---- | ---- | 2.78%668.03K | ---- | ---- | ---- | ---- | 76.20%649.96K | ---- |
| Non-operating interest expense | -7.07%92K | -3.85%100K | -27.69%94K | 5.78%145.04K | -2.03%145K | 0.00%99K | 13.04%104K | 15.04%130K | 55.28%137.11K | 164.43%148K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -104.79%-14.42K | 129.56%300.96K | ||||||||
| Special income (charges) | -34,374.79%-481.27K | 99.73%-1.4K | ||||||||
| Less:Write off | ---- | ---- | ---- | 34,374.79%481.27K | ---- | ---- | ---- | ---- | -99.73%1.4K | ---- |
| Other non-operating income (expenses) | 523.26%536K | 13.83%535K | -17.21%534K | -1.60%1.78M | 158.48%579K | -83.74%86K | -29.96%470K | 67.53%645K | 1.81M | 224K |
| Income before tax | 185.04%1.3M | 168.02%1.07M | -146.57%-768K | -42.29%-1.84M | 96.22%-20K | -205.59%-1.53M | -286.42%-1.58M | 251.28%1.65M | -163.32%-1.29M | -44.72%-529K |
| Income tax | 17.05%151K | -5.60%118K | 176.80%346K | -57.02%141.21K | 132.99%128K | -63.87%129K | -30.56%125K | -30.56%125K | -81.20%328.55K | -179.04%-388K |
| Net income | 169.34%1.15M | 156.10%956K | -173.10%-1.11M | -22.18%-1.98M | -4.96%-148K | -93.47%-1.66M | -355.47%-1.7M | 220.00%1.52M | 27.53%-1.62M | 83.54%-141K |
| Net income continuous operations | 169.34%1.15M | 156.10%956K | -173.10%-1.11M | -22.18%-1.98M | -4.96%-148K | -93.47%-1.66M | -355.47%-1.7M | 220.00%1.52M | 27.53%-1.62M | 83.54%-141K |
| Noncontrolling interests | -1,150.00%-25K | -83.33%-11K | -101.59%-1K | 116.18%25.97K | 57.53%-31K | 83.33%-2K | -115.79%-6K | 155.75%63K | 65.03%-160.46K | 65.38%-73K |
| Net income attributable to the company | 170.93%1.18M | 156.95%967K | -176.18%-1.11M | -37.36%-2.01M | -72.06%-117K | -95.98%-1.66M | -369.95%-1.7M | 226.27%1.46M | 17.87%-1.46M | 89.47%-68K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 170.93%1.18M | 156.95%967K | -176.18%-1.11M | -37.36%-2.01M | -72.06%-117K | -95.98%-1.66M | -369.95%-1.7M | 226.27%1.46M | 17.87%-1.46M | 89.47%-68K |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 169.57%0.0016 | 154.17%0.0013 | -175.00%-0.0015 | -40.00%-0.0028 | -100.00%-0.0002 | -91.67%-0.0023 | -366.67%-0.0024 | 225.00%0.002 | 20.00%-0.002 | 88.89%-0.0001 |
| Diluted earnings per share | 169.57%0.0016 | 154.17%0.0013 | -175.00%-0.0015 | -40.00%-0.0028 | -100.00%-0.0002 | -91.67%-0.0023 | -366.67%-0.0024 | 225.00%0.002 | 20.00%-0.002 | 88.89%-0.0001 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.